ZA867670B - Method for alleviation of panic disorders - Google Patents

Method for alleviation of panic disorders

Info

Publication number
ZA867670B
ZA867670B ZA867670A ZA867670A ZA867670B ZA 867670 B ZA867670 B ZA 867670B ZA 867670 A ZA867670 A ZA 867670A ZA 867670 A ZA867670 A ZA 867670A ZA 867670 B ZA867670 B ZA 867670B
Authority
ZA
South Africa
Prior art keywords
alleviation
panic disorders
panic
disorders
agoraphobia
Prior art date
Application number
ZA867670A
Other languages
English (en)
Inventor
Neil M Kurtz
Roger E Newton
Davis L Temple Jr
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ZA867670B publication Critical patent/ZA867670B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA867670A 1985-10-25 1986-10-08 Method for alleviation of panic disorders ZA867670B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/791,182 US4634703A (en) 1985-10-25 1985-10-25 Method for alleviation of panic disorders

Publications (1)

Publication Number Publication Date
ZA867670B true ZA867670B (en) 1987-06-24

Family

ID=25152914

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA867670A ZA867670B (en) 1985-10-25 1986-10-08 Method for alleviation of panic disorders

Country Status (11)

Country Link
US (1) US4634703A (xx)
EP (1) EP0220696B1 (xx)
JP (1) JPH0667841B2 (xx)
AT (1) ATE86858T1 (xx)
AU (1) AU592121B2 (xx)
CY (1) CY1786A (xx)
DE (1) DE3688038T2 (xx)
ES (1) ES2053429T3 (xx)
GR (1) GR3007393T3 (xx)
HK (1) HK87094A (xx)
ZA (1) ZA867670B (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4777173A (en) * 1987-03-25 1988-10-11 Bristol-Myers Company Method for treatment of alcohol abuse
US4782060A (en) * 1987-07-29 1988-11-01 Bristol-Myers Company Gepirone for alleviation of panic disorders
SE8704097D0 (sv) * 1987-10-22 1987-10-22 Astra Ab Oral formulation of buspirone and salts thereof
DE3736974A1 (de) * 1987-10-31 1989-05-11 Troponwerke Gmbh & Co Kg Verwendung von 2-pyrimidinyl-1-piperazin-derivaten
US5468749A (en) * 1988-08-30 1995-11-21 Gawin; Frank H. Method for treatment of substance addiction
US6432956B1 (en) 1990-02-12 2002-08-13 William C. Dement Method for treatment of sleep apneas
US5166202A (en) * 1990-09-19 1992-11-24 Trustees Of The University Of Pennsylvania Method for the treatment of panic disorder
US5633009A (en) * 1990-11-28 1997-05-27 Sano Corporation Transdermal administration of azapirones
JPH04327532A (ja) * 1991-01-31 1992-11-17 Bristol Myers Squibb Co 活動過剰を伴う注意力欠乏疾患の治療に使用する医薬製剤
US5431922A (en) * 1991-03-05 1995-07-11 Bristol-Myers Squibb Company Method for administration of buspirone
US5457100A (en) * 1991-12-02 1995-10-10 Daniel; David G. Method for treatment of recurrent paroxysmal neuropsychiatric
US5900250A (en) * 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
JPH08500577A (ja) * 1992-07-15 1996-01-23 ユニヴァーシティ オブ サウス フロリダ パニック障害の治療に関連するｃｃｋペプチドの血中濃度
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
WO1995009006A1 (en) * 1993-09-29 1995-04-06 Alza Corporation Monoglyceride/lactate ester permeation enhancer
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
GB9706089D0 (en) * 1997-03-24 1997-05-14 Scherer Ltd R P Pharmaceutical composition
US8134029B2 (en) 2002-09-16 2012-03-13 Sunovion Pharmaceuticals Inc. Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
US7588732B2 (en) * 2004-03-30 2009-09-15 Genesis Biosystems, Inc. Autologus tissue harvesting and irrigation device
JP2009500425A (ja) 2005-07-06 2009-01-08 セプラコア インコーポレーテッド エスゾピクロン及びトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−ｎ−メチル−１−ナフタレンアミン又はトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−１−ナフタレンアミンの組み合わせ、並びに閉経期並びに気分、不安、及び認知障害の治療方法
DK2013835T3 (en) * 2006-03-31 2015-12-14 Sunovion Pharmaceuticals Inc Preparation of chiral amides and AMINES
WO2008036846A2 (en) * 2006-09-22 2008-03-27 Braincells, Inc. Combination comprising an hmg-coa reductase inhibitor and a second neurogenic agent for treating a nervous system disorder and increasing neurogenesis
US20120077818A1 (en) * 2009-05-13 2012-03-29 Sunovion Pharmaceuticals Inc. Compositions comprising transnorsertraline and serotonin receptor 1a agonists/antagonists and uses thereof
RU2660583C1 (ru) * 2017-08-15 2018-07-06 Общество С Ограниченной Ответственностью "Валента - Интеллект" Применение буспирона для лечения функционального головокружения

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987052A (en) * 1969-03-17 1976-10-19 The Upjohn Company 6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
US4508726A (en) * 1982-09-16 1985-04-02 The Upjohn Company Treatment of panic disorders with alprazolam
US4438119A (en) * 1982-12-23 1984-03-20 Mead Johnson & Company Method for alleviation of extrapyramidal motor disorders

Also Published As

Publication number Publication date
DE3688038D1 (de) 1993-04-22
AU6424586A (en) 1987-04-30
US4634703A (en) 1987-01-06
DE3688038T2 (de) 1993-07-01
JPS62111924A (ja) 1987-05-22
CY1786A (en) 1995-10-20
JPH0667841B2 (ja) 1994-08-31
ATE86858T1 (de) 1993-04-15
EP0220696A2 (en) 1987-05-06
ES2053429T3 (es) 1994-08-01
HK87094A (en) 1994-09-02
EP0220696B1 (en) 1993-03-17
GR3007393T3 (xx) 1993-07-30
AU592121B2 (en) 1990-01-04
EP0220696A3 (en) 1989-10-04

Similar Documents

Publication Publication Date Title
ZA867670B (en) Method for alleviation of panic disorders
IT8523299A0 (it) Derivati. processo per la preparazione di (2,2)-paraciclofano e suoi
ZA853026B (en) Leukemia-associated virus immunogen,vaccine and assay
IT8819077A0 (it) Processo per la preparazione di 1,2 difluoroetano e di 1,1,2trifluoroetano.
ITRM920412A1 (it) Eteroprostanoidi, procedimento per la loro preparazione e loro impiego terapeutico.
EG18730A (en) Substituted tetralin, chromans and related compounds in the treatment of asthma, arthritis and related diseases
IT8748428A0 (it) Procedimento per la formazione di contenitori,in particolare lattine
IT8522667A0 (it) Processo per la preparazione di (2,2)-paraciclofano.
IT8667677A1 (it) Procedimento e apparecchiatura per la formazione di masse refrattarie.
IT8820935A0 (it) Procedimento per la preparazione di 1,2,5,6,9,10 esabromociclododecano.
ES553377A0 (es) Procedimiento para la produccion de 2,4,6-tris-(amino-fenilamino)-triacinas
ITTO920516A0 (it) Procedimento ed apparecchiatura per la rpoduzione, in particolare domestica, di bevande.
IT8420213A0 (it) Procedimento per la preparazione di 1,8-diidrossi-10-acil-9-antroni, in particolare per l'uso nel trattamento di psoriasi.
FR2588848B1 (fr) Aluminates mixtes de lanthane-magnesium, leur procede de fabrication et lasers utilisant ces aluminates
NO874694D0 (no) Begrenset inngangsmetode for samtidig indusering av flere frakturer i avviksbroenner.
ZA885517B (en) Gepirone for alleviation of panic disorders
IT1190604B (it) Procedimento per la preparazione di 4,4-dialchil-2-azetidinoni
IT1187655B (it) Procedimento per la preparazione di w-lattami,in particolare caprolattame
DE3666666D1 (en) Early-summer meningo-encephalitis virus (fsme-virus) vaccine, and method of producing the same
IT8722055A0 (it) Procedimento per la preparazione di idantoine 5-ariliden e alchilidensostituite.
IT8721683A0 (it) Procedimento per la reidratazione rapida di legumi e simili, nonche'apparecchiatura per la reidratazione rapida ed in continuov di legumi e simili.
IT8622780A0 (it) "2-cloro-12-(-3-dimetilammino-2-metilpropil)-12h-dibenzo-/d,g//1,3,6/d iossazocine otticamente attive eprocedimento per la loro preparazione.
MX156323A (es) Procedimiento para la preparacion de hidroxiantraquinonas,hidroxinaftaquinonas e hidroquinonas
ES2019335B3 (es) Metodo para la preparacion de anilinofumarato y acido quinolein-2,3-dicarboxilico.
IT1197941B (it) Procedimento per la realizzazione di coperte, e prodotto ottenuto